Vermont Medical Sleep Disorder Essex Junction, VT - 05452

Vermont Medical Sleep Disorder is categorized under Doctors in Essex Junction, VT .

Vermont Medical Sleep Disorder was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6219996 by the NAICS.

If you are seeking more information, feel free to contact Ray Paquette, President at the company’s single location by writing to 139 Pearl St, Essex Junction, Vermont VT 05452 or by phoning (802) 878-4445. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Vermont Medical Sleep Disorder
Contact Person: Ray Paquette, President
Address: 139 Pearl St, Essex Junction, Vermont 05452
Phone Number: (802) 878-4445
Website Address: vermontsleepdisorders.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6219996
Share This Business:

Vermont Medical Sleep Disorder was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6219996. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Ray Paquette, President for inquiries that concern Vermont Medical Sleep Disorder by calling the company number (802) 878-4445, as your correspondence is most welcome. Additionally, the physical location of the single location of Vermont Medical Sleep Disorder can be found at the coordinates 44.497049,-73.125697 as well as the street address 139 Pearl St in Essex Junction, Vermont 05452.

For its online presence, you may visit Vermont Medical Sleep Disorder’s website at vermontsleepdisorders.com and engage with its social media outlets through on Twitter and on Facebook.